Skip to Accessibility Tools Skip to Content Skip to Footer

Complera

Complera is a combination medication that contains rilpivirine, emtricitabine, and tenofovir disoproxil fumarate. It is used as a standalone antiretroviral therapy (ART) regimen for HIV-1 in individuals who are at least 12 years of age, have never taken any other HIV medicines before, and who have a viral load (amount of virus in the blood) of less than 100,000 copies per mL. Individuals taking Complera should be at least 77 pounds (35 kg). Complera may be used in individuals who are replacing a stable ART regimen, have not had any previous treatment failures, and who have had a viral load of 50 copies per mL or less on a stable ART regimen for at least six months.

Although it is not a cure for HIV, when taken as directed, it allows for the virus to be suppressed. This prevents further transmission of HIV and allows an individual’s immune system to improve through increasing CD4 cell counts and decreasing viral load.

What are the ingredients in Complera?

The main ingredients in Complera are rilpivirine, emtricitabine, and tenofovir disoproxil fumarate. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), while emtricitabine, and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs).

How does Complera work?

Complera is a combination of two NRTI medications and one NNRTI medication. Both types of drugs stop the reverse transcription step of the HIV life cycle. Normally, HIV uses its reverse transcriptase enzyme to build a strand of DNA from its original RNA form. In order to do this, it uses genetic building blocks called nucleosides that come from the host cell. These nucleosides are strung together one at a time, like beads on a string, to create the final DNA product.

NRTIs act as nucleoside mimics that stop the DNA-building process. NRTIs look like normal nucleosides, except they’re missing a special chemical group on one side. Without this group, the reverse transcriptase enzyme is unable to attach more nucleosides to the chain after them.

NNRTIs bind to the reverse transcriptase enzyme itself to stop the DNA-building process. When an NNRTI binds to reverse transcriptase, the enzyme is unable to attach more nucleosides to the chain. Both of these mechanisms block the full string of DNA from being formed, preventing HIV RNA from making it all the way through the reverse transcription process and into host DNA for further replication.

What are the possible side effects of Complera?

The most common side effects of Complera include, but are not limited to:

  • Nausea
  • Diarrhea
  • Fatigue
  • Dizziness
  • Abnormal dreams
  • Rash
  • Depressive disorders
  • Insomnia
  • Headache

Things to note about Complera

As with any medication, there are several very rare but serious risks that need to be considered before taking Complera. Your healthcare provider can help determine what issues you may be at risk for and help determine what treatment options are the safest for you. It’s also important to remember that the risk of one or more of these issues occurring is low, and the benefits of treating the virus often greatly outweigh the risks.

Several of these rare but serious side effects of Complera include liver issues and an increase of lactic acid in the blood (lactic acidosis). Signs of liver issues include, but are not limited to:

  • Dark-colored urine
  • Loss of appetite
  • Nausea
  • Yellowing of the whites of the eyes or skin
  • Light-colored bowel movements
  • Pain or tenderness on the right side of your stomach

Signs of lactic acidosis include, but are not limited to:

  • Trouble breathing
  • Feeling cold, especially in the limbs
  • Dizziness or lightheadedness
  • Feeling tired or weak
  • Muscle pain
  • Nausea and vomiting
  • Irregular or fast heartbeat

If you have hepatitis B virus and start taking Complera, your hepatitis B may get worse. Complera may also cause new or worsening kidney issues. This includes an increased risk of kidney failure. Your healthcare provider will need to monitor your kidney function before you start and while taking Complera. Bone issues may also happen while taking Complera, including, but not limited to, bone pain, thinning, or softening. These problems may lead to bone fractures.

Serious psychiatric issues such as depression or mood changes may occur. Contact your healthcare provider as soon as possible if you experience these or any suicidal thoughts or ideations.

Before starting Complera, tell your doctor if you:

  • Have or previously had hepatitis B virus
  • Have or previously had hepatitis C virus
  • Have a history of liver or kidney problems
  • Have a history of bone problems
  • Have a history of mental illness, depression, or suicidal thoughts
  • Are pregnant or planning to become pregnant
  • Are breastfeeding or planning to breastfeed
  • Are taking any over-the-counter vitamins, supplements, medicines, or herbal remedies
  • Are on any other medications or are about to start any other medications, including hormonal birth control, seizure medications, or medications for hepatitis viruses

There are many medications that cannot be taken with Complera. It is important to tell your doctor about any and all medications you are taking to ensure you are taking Complera safely.

Rarely, skin rashes or allergic reactions may occur with Complera and may be serious. Alert your healthcare provider if you notice any of the following:

  • Skin blisters
  • Mouth sores
  • Swelling of the lips, mouth, face, or throat
  • Pain on right side of the stomach
  • Fever
  • Trouble breathing or swallowing
  • Dark-colored urine
  • Redness or swelling of the eyes

Complera may cause a condition called IRIS (immune reconstitution inflammatory syndrome). IRIS occurs when an individual’s immune system gets stronger after being weak and responds aggressively to previously hidden infections. This heightened response may make the person fighting the infection feel worse. Alert your healthcare provider immediately if you begin to have new symptoms after taking Complera.

Dosing information

The most common dosage of Complera is one tablet taken by mouth once a day. A tablet contains 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate. It is important to take your medication exactly as prescribed, and to not stop or change your Complera dosage without talking to your healthcare provider first. Complera should be taken with food.

If you miss a dose of Complera, and it is within 12 hours of when you normally take the medicine, take the tablet with food as soon as you remember and your next regularly scheduled dose at its normal time with food. However, if it is after 12 hours since you missed a dose, just take your next dose only at its normally scheduled time and with food. If you take too much Complera, seek medical attention immediately.1,2

Written by: Casey Hribar | Last reviewed: September 2019
  1. Complera. United States Department of Health and Human Services: AIDSinfo. https://aidsinfo.nih.gov/drugs/441/complera/0/patient. Published December 19, 2018. Accessed July 20, 2019.
  2. Complera Prescribing Information. Gilead Sciences, Inc. https://www.gilead.com/-/media/files/pdfs/medicines/hiv/complera/complera_pi.pdf. Published October 2018. Accessed July 20, 2019.